Transcatheter aortic valve implantation significantly reduced mitral regurgitation severity, with aFMR patients showing the greatest improvement.
Does transcatheter aortic valve implantation (TAVI) improve mitral regurgitation severity and symptoms across different MR aetiologies?
TAVI effectively reduces mitral regurgitation severity and symptoms, with the most significant improvement seen in patients with atrial functional mitral regurgitation.
TAVI reduces MR severity and symptoms in patients with aFMR, vFMR and less-pronounced PMR. The presence of aFMR was associated with the greatest MR severity improvement.
Doldi et al. (2023) studied this question. Transcatheter aortic valve implantation significantly reduced mitral regurgitation severity, with aFMR patients showing the greatest improvement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: